These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

46 related articles for article (PubMed ID: 25935363)

  • 41. Drafting a blueprint for the design of a rare disease ecosystem in Slovenia: Identifying salient opportunities and outlining policy recommendations.
    Stanimirovic D; Murko E; Battelino T; Groselj U; Zerjav Tansek M
    J Glob Health; 2021; 11():03064. PubMed ID: 34471521
    [No Abstract]   [Full Text] [Related]  

  • 42. Policy recommendations for rare disease centres of expertise.
    Syed AM; Camp R; Mischorr-Boch C; Houÿez F; Aro AR
    Eval Program Plann; 2015 Oct; 52():78-84. PubMed ID: 25935363
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bridging the Gap between Health and Social Care for Rare Diseases: Key Issues and Innovative Solutions.
    Castro R; Senecat J; de Chalendar M; Vajda I; Dan D; Boncz B;
    Adv Exp Med Biol; 2017; 1031():605-627. PubMed ID: 29214594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reference centres for adults with rare and complex cancers - Policy recommendations to improve the organisation of care in Belgium.
    Stordeur S; Vrijens F; Leroy R
    Rev Epidemiol Sante Publique; 2016 Feb; 64(1):1-6. PubMed ID: 26745998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Policies and actions to tackle rare diseases at European level.
    Montserrat A; Taruscio D
    Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transthyretin amyloidosis: Testing strategies and model for center of excellence support.
    Nakov R; Sarafov S; Gospodinova M; Kirov A; Chamova T; Todorov T; Todorova A; Tournev I
    Clin Chim Acta; 2020 Oct; 509():228-234. PubMed ID: 32564944
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]     [New Search]
    of 3.